Showing results (851-860 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|October 2, 2008
AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effectsMichael R Graham, Peter Evans, Bruce Davies, et al.Therapeutics and Clinical Risk Management|October 2, 2008
Treatment strategies in mucous membrane pemphigoidAnn G Neff, Matthew Turner, Diya F MutasimTherapeutics and Clinical Risk Management|October 2, 2008
Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantationHideki Ishida, Kazunari TanabeTherapeutics and Clinical Risk Management|March 4, 2015
Reducing drug-herb interaction risk with a computerized reminder systemSheng-Shing Lin, Chiu-Lin Tsai, Ching-Yeh Tu, et al.Therapeutics and Clinical Risk Management|March 4, 2015
Factors that increase external pressure to the fibular head region, but not medial region, during use of a knee-crutch/leg-holder system in the lithotomy positionJu Mizuno, Toru TakahashiTherapeutics and Clinical Risk Management|March 10, 2015
Advances in diagnosis and treatment of trigeminal neuralgiaNicola Montano, Giulio Conforti, Rina Di Bonaventura, et al.Therapeutics and Clinical Risk Management|March 10, 2015
Clinical use of azelnidipine in the treatment of hypertension in Chinese patientsBi-Lian Chen, Yin-Zhuang Zhang, Jian-Quan Luo, et al.Therapeutics and Clinical Risk Management|March 10, 2015
Role of physiotherapy and patient education in lymphedema control following breast cancer surgeryShiang-Ru Lu, Rong-Bin Hong, Willy Chou, et al.Therapeutics and Clinical Risk Management|April 11, 2023
Comparison and Optimization of Cardiovascular Risk Scores in Predicting the 4-Year Outcome of Patients with Obstructive Coronary Arteries DiseaseTaichun Qiu, Chunxiao Liang, Bing Ming, et al.Therapeutics and Clinical Risk Management|July 9, 2020
Oxygen-Ozone (O2-O3) Therapy in Peripheral Arterial Disease (PAD): A Review StudyHanna Juchniewicz, Anna LubkowskaPageof 256